The vaccine is under the human trial phase and once the effectiveness is proved, the pharma company will produce millions of doses in a couple of months. While the company will produce the first 100 million doses for the UK as per its deal signed with the nation, it will manufacture around 2 billion doses to be supplied worldwide by mid-2021.Original Article
You may also like
A Temporary Extension for the Rare Pediatric Disease...
Survey Says 25% Of Adults In U.S Suspect They Have...
Your Child’s Bedtime Affects Their Gut Health:...
Quality, Not Quantity Of Good Cholesterol Linked To...
Atueyi Tasks Pharmacy Students on Critical Thinking
Best Oil Cleansers: Top Solutions For Deep Cleansing...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.